中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
7期
48-49,50
,共3页
糖尿病%2型%胰岛素泵%优泌林R%赖脯胰岛素
糖尿病%2型%胰島素泵%優泌林R%賴脯胰島素
당뇨병%2형%이도소빙%우비림R%뢰포이도소
Diabetes mellitus%Type 2%Insulin pump%Iinsulin Lispro%Humulin R
目的:比较胰岛素泵输注赖脯胰岛素(优泌乐)与重组人胰岛素(优泌林R)治疗初诊2型糖尿病的疗效及安全性。方法:选择45例本院初诊2型糖尿病患者行胰岛素泵强化治疗,并按随机数字表法分为优泌乐组和优泌林R组,比较两组各点血糖、血糖达标时间、血糖达标时胰岛素用量及低血糖发生率。结果:优泌乐组的血糖达标时间较优泌林R组短,胰岛素用量也较少,餐后血糖值更低,差异均有统计学意义(P<0.05);但两组餐前血糖及睡前血糖比较差异无统计学意义(P>0.05)。结论:用胰岛素泵输注优泌乐和优泌林R均能安全、有效的控制初诊2型糖尿病高血糖状态,但优泌乐组血糖达标时间更短,餐后血糖控制更佳,所需胰岛素量更少。
目的:比較胰島素泵輸註賴脯胰島素(優泌樂)與重組人胰島素(優泌林R)治療初診2型糖尿病的療效及安全性。方法:選擇45例本院初診2型糖尿病患者行胰島素泵彊化治療,併按隨機數字錶法分為優泌樂組和優泌林R組,比較兩組各點血糖、血糖達標時間、血糖達標時胰島素用量及低血糖髮生率。結果:優泌樂組的血糖達標時間較優泌林R組短,胰島素用量也較少,餐後血糖值更低,差異均有統計學意義(P<0.05);但兩組餐前血糖及睡前血糖比較差異無統計學意義(P>0.05)。結論:用胰島素泵輸註優泌樂和優泌林R均能安全、有效的控製初診2型糖尿病高血糖狀態,但優泌樂組血糖達標時間更短,餐後血糖控製更佳,所需胰島素量更少。
목적:비교이도소빙수주뢰포이도소(우비악)여중조인이도소(우비림R)치료초진2형당뇨병적료효급안전성。방법:선택45례본원초진2형당뇨병환자행이도소빙강화치료,병안수궤수자표법분위우비악조화우비림R조,비교량조각점혈당、혈당체표시간、혈당체표시이도소용량급저혈당발생솔。결과:우비악조적혈당체표시간교우비림R조단,이도소용량야교소,찬후혈당치경저,차이균유통계학의의(P<0.05);단량조찬전혈당급수전혈당비교차이무통계학의의(P>0.05)。결론:용이도소빙수주우비악화우비림R균능안전、유효적공제초진2형당뇨병고혈당상태,단우비악조혈당체표시간경단,찬후혈당공제경가,소수이도소량경소。
Objective:To compare the efficacy and safety of insulin Lispro and Humulin R via continuous subcutaneous insulin infusion pump on hyperglycemia in newly-diagnosed 2 diabetes. Method:45 patients accepted a 2-week course of intensive CsII were selected. They were divided into group A(n=25)and group B(n=20)according to random number table method. The group A was treated with insulin Lispro,the group B was treated with Humulin R. The therapeutic effects were measured after therapy. Result:The time for good glycemia control was shorter in the group A than that in the group B(P<0.05);the mean of three postprandial blood glucose were significantly lower in the group A than that in the group B,with lower total insulin dosage,the differences were statistically significant(P<0.05);but no differences in blood glucose between the two groups were observed in bedtime and before three meals(P>0.05). Conclusion:Insulin Lispro via continuous subcutaneous insulin infusion pump is as efficacious and safe as Humulin R in controlling hyperglycemia in newly-diagnosed type 2 diabetes,but insulin Lispro provides a more effective and faster control of postprandial hyperglycemia with less insulin used.